div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: geciczmpcomgeciczmpcomDataSites1docsproject-documents3rdmeetpdf · and financial targets during current financial year The committee approved the AAP of Rs 2166 crores src=https:reader033vdocumentsusreader033viewer20220520046017e5ce0593da35463c51d8html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: geciczmpcomgeciczmpcomDataSites1docsproject-documents3rdmeetpdf · and financial targets during current financial year The committee approved the AAP of Rs 2166 crores src=https:reader033vdocumentsusreader033viewer20220520046017e5ce0593da35463c51d8html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: geciczmpcomgeciczmpcomDataSites1docsproject-documents3rdmeetpdf · and financial targets during current financial year The committee approved the AAP of Rs 2166 crores src=https:reader033vdocumentsusreader033viewer20220520046017e5ce0593da35463c51d8html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: geciczmpcomgeciczmpcomDataSites1docsproject-documents3rdmeetpdf · and financial targets during current financial year The committee approved the AAP of Rs 2166 crores src=https:reader033vdocumentsusreader033viewer20220520046017e5ce0593da35463c51d8html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: geciczmpcomgeciczmpcomDataSites1docsproject-documents3rdmeetpdf · and financial targets during current financial year The committee approved the AAP of Rs 2166 crores src=https:reader033vdocumentsusreader033viewer20220520046017e5ce0593da35463c51d8html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdiv